Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S <i>LRRK2</i> carriersKyle Fraser, Birgitt Schüele, Alexis Brice et al.|Neurology|2016Cited by 138
Clinicogenetic study of mutations in <i>LRRK2</i> exon 41 in Parkinson's disease patients from 18 countriesHiroyuki Tomiyama, Nobutaka Hattori, Yuanzhe Li et al.|Movement Disorders|2006Cited by 111
Clinical Features of Parkinson Disease Patients With Homozygous Leucine-Rich Repeat Kinase 2 G2019S MutationsLianna Ishihara, Fayçal Hentati, Liling Warren et al.|Archives of Neurology|2006Cited by 103
Autosomal recessive parkinsonism linked to parkin gene in a Tunisian family. Clinical, genetic and pathological studyN. Gouider‐Khouja, Fayçal Hentati, A. Larnaout et al.|Parkinsonism & Related Disorders|2003Cited by 93
Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease familiesLianna Ishihara, Fayçal Hentati, Rachel A. Gibson et al.|Movement Disorders|2006Cited by 92